SZ7-26289-78394
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-25
Dose 2 — Pfizer-BioNTech
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-30
- 2021-06-06
- 2021-07-25
- 2021-10-24
-
2021-12-16
Dose 3 — Pfizer-BioNTech
- 2022-04-25
-
2022-06-16
Survey response — 6 months, dose 3MedDRA: Fatigue, Headache, Myalgia, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Congestion, runny rose, fatigue, muscle aches, headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Survey response — 12 months, dose 3MedDRA: COVID-19, Ear infection, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID-19, RSV, Ear InfectionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-25 | Pfizer-BioNTech | |
| 3 | 2021-12-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 6 months, dose 3
Symptoms: Congestion, runny rose, fatigue, muscle aches, headaches
Release 12 — 12 months, dose 3
Symptoms: COVID-19, RSV, Ear Infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release